A randomized, double-blind, parallel controlled clinical study of tangerine peel enzyme in the treatment of insomnia with deficiency of heart and spleen

Authors
Category Primary study
Registry of TrialsITMCTR
Year 2022
INTERVENTION: Test group:Orange peel enzyme concentrated juice, 1 tube each time, twice a day, oral. Provided by Guangdong xinbaotang Biotechnology Co., Ltd; The course of treatment was 4 weeks.;control group:Tangerine peel enzyme simulant (the specification, appearance and packaging are the same as those of the test group), one at a time, twice a day, orally. Provided by Guangdong xinbaotang Biotechnology Co., Ltd. The course of treatment was 4 weeks.; CONDITION: insomnia PRIMARY OUTCOME: Pittsburgh sleep index scale total score; SECONDARY OUTCOME: Patient depression self assessment tool (PHQ‐9);Generalized anxiety scale (GAD‐7);Insomnia TCM quality of life scale (tcmqli‐21); INCLUSION CRITERIA: (1) Over 18 years old. (2) The diagnosis of chronic insomnia meets the Western medical standard. (3) It meets the standard of deficiency syndrome of heart and spleen in traditional Chinese medicine. (4) Pittsburgh sleep quality inde X(PSQI) total score > 7 (5) Sign informed consent
Epistemonikos ID: ceef970d892160f6fc3b41ccfe174f332c1e8c95
First added on: Aug 26, 2024